Related references
Note: Only part of the references are listed.Small artery dilation and endothelial markers in cardiovascular risk patients
Gemma Aragones et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2012)
Different association of circulating levels of adipocyte and epidermal fatty acid-binding proteins with metabolic syndrome and coronary atherosclerosis in Chinese adults
Jie Hong et al.
ATHEROSCLEROSIS (2011)
Chronic administration of BMS309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells
Mary Y. K. Lee et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Association of increased plasma adipocyte fatty acid-binding protein with coronary artery disease in non-elderly men
Masayuki Doi et al.
CARDIOVASCULAR DIABETOLOGY (2011)
Heart-Type Fatty Acid Binding Protein (H-FABP): Relationship with arterial intima-media thickness and role as diagnostic marker for atherosclerosis in patients with impaired glucose metabolism
Basak Karbek et al.
CARDIOVASCULAR DIABETOLOGY (2011)
Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity
Hong Lan et al.
JOURNAL OF LIPID RESEARCH (2011)
Fatty acid-binding protein 4 is associated with endothelial dysfunction in patients with type 2 diabetes
Gemma Aragones et al.
ATHEROSCLEROSIS (2010)
FABP4 plasma levels are increased in familial combined hyperlipidemia
Anna Cabre et al.
JOURNAL OF LIPID RESEARCH (2010)
Endothelial dysfunction in diabetes mellitus: Molecular mechanisms and clinical implications
Corey E. Tabit et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2010)
Adipocyte Fatty Acid-Binding Protein Suppresses Cardiomyocyte Contraction A New Link Between Obesity and Heart Disease
Valeria Lamounier-Zepter et al.
CIRCULATION RESEARCH (2009)
The fatty acid binding protein-4 (FABP4) is a strong biomarker of metabolic syndrome and lipodystrophy in HIV-infected patients
Blai Coll et al.
ATHEROSCLEROSIS (2008)
Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes
Anna Cabre et al.
JOURNAL OF LIPID RESEARCH (2008)
Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis
D. C. Y. Yeung et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Endothelial dysfunction in insulin resistance and type 2 diabetes
P.-A. Jansson
JOURNAL OF INTERNAL MEDICINE (2007)
Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome - A 5-year prospective study
Aimin Xu et al.
CIRCULATION (2007)
Lipid metabolism mediated by adipocyte lipid binding protein (ALBP/aP2) gene expression in human THP-1 macrophages
Yuchang Fu et al.
ATHEROSCLEROSIS (2006)
Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome?
D. Stejskal et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2006)
Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome
AM Xu et al.
CLINICAL CHEMISTRY (2006)
Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease
GK Hansson
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis
JB Boord et al.
CURRENT OPINION IN LIPIDOLOGY (2002)
Fatty acid binding protein expression in different adipose tissue depots from lean and obese individuals
RM Fisher et al.
DIABETOLOGIA (2001)
Share Paper
